Clinical Trial Update: Hostility Reduction Program to Improve Autonomic Regulation of the Heart [NA]

View source ↗

Summary

A National Heart, Lung, and Blood Institute–sponsored clinical trial completed a hostility-reduction program aimed at improving autonomic regulation of the hear…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Hostility, Coronary Arteriosclerosis | NA | Status: COMPLETED